Proposal of modification of the diagnostic approaches de neurofibromatosis type 1

Authors

Keywords:

Genodermatoses, Medical genetics, Neurofibromatosis, Legius syndrome.

Abstract

Of the patients with Legius syndrome, 2 % completes the diagnostic approaches of neurofibromatosis type since 1 they present brown stain with milk and sign of Crowe, this makes indistinguishable the two diseases. The objective of the study was to evaluate the proposal of modification of the diagnostic approaches of neurofibromatosis type 1. Was carried out in The Tunas, a quasi-experimental study. By means of the varying Delphi of the method of experts, the proposal of modification of the diagnostic approaches of the neurofibromatosis type 1 were designed. The sample corresponded with 119 patients that complete the approaches of the neurofibromatosis type 1. Was carried out molecular genetic study for neurofibromatosis type 1 to those that completed alone with the brown presence of stains with milk and sign of Crowe. When the molecular exam was negative, it was considered the diagnosis of Legius syndrome. Proportion was studied of patient according to the manifestations, positivity index, exact test of Fisher and adjusted correction of Yachts with p≤0.05 and to determine the agreement grade between current approaches and the modified approaches the index Kappa of Cohen it was determined. Most of the patients that alone they presented brown stains with milk associated to the sign of Crowe without other manifestations, they were negative to the molecular genetic study for neurofibromatosis 1, they were diagnosed as Legius syndrome. When evaluating the effectiveness of the proposed modified approaches it was determined that they allow to carry out the diagnosis of neurofibromatosis type 1 with 95 % of dependability, avoiding the error diagnoses with the Legius syndrome.

Downloads

Download data is not yet available.

Author Biographies

Yordania Velázquez Avila, Hospital Pediátrico Provincial Docente "Mártires de Las Tunas", Las Tunas

Especialista de segundo grado de Dermatología, Master en Enfermedades Infecciosas, Profesora asistente, Investigadora agregada.

Teresa Petra Rodríguez Torres, Hospital Pediátrico Provincial Docente “Mártires de Las Tunas”. Las Tunas

Especialista de segundo grado en pediatría, Master en Atención integral al niño, profesora auxiliar.

Lisdany Rodríguez Carbonell, Hospital Pediátrico Provincial Docente “Mártires de Las Tunas”. Las Tunas

Especialista de primer grado de pediatría

Orendys Feria Rosales, Hospital Pediátrico Provincial Docente “Mártires de Las Tunas”. Las Tunas

Médico residente de pediatría

Yasaris López Toranzo, Hospital Provincial General Docente “Dr. Ernesto Guevara de la Serna”. Las Tunas.

Especialista de primer grado en dermatología, profesora asistente

References

1. Herrero castilla A. Rasopatías y sus alteraciones cardiológicas en pacientes con alteración genética confirmada. [Tesis]. Salamanca: Universidad de Salamanca; 2022 [citado 20/12/2024]. Disponible en: https://gredos.usal.es/bitstream/handle/10366/150137/TG_%c3%81ngela_HerreroCastilla_Rasopat%c3%adas_y_sus_alteraciones_cardiol%c3%b3gicas_en_pacientes.pdf?sequence=1&isAllowed=y .

2. Online Mendelian Inheritance in Man. Neurofibrormatosis type 1[Internet]. Baltimore: OMIM. 2024 [citado 13/08/2024]. Disponible en: https://omim.org/162200 .

3. Orpanet. Neurofibromatosis tipo 1 [Internet]. Paris: Orphanet. 2020 [citado 15/08/2021] Disponible en: https://www.orpha.net/636 .

4. Genetic and Rare Diseases Information Center. Neurofibormatosis type 1. Gaithersburg: GARD [Internet]. 2024 [citado 15/08/2024] Disponible en: https://rarediseases.info.nih.gov/diseases/7866/index .

5. Deloya F, García A. Neurofibromatosis tipo I. Etiología, diagnóstico y tratamiento. CIENCIA UANL [Internet]. 2024 [citado 21/02/2025]; 27(123):31-6. Disponible en: https://doi.org/10.29105/cienciauanl27.123-4 .

6. García FJ, Hernández A. Cronología del diagnóstico de la neurofibromatosis tipo 1 en la infancia. ACTAS Dermo-Sifiliográficas [Internet]. 2023 [citado 21/02/2025]; 114:187-93. Disponible en: https://www.actasdermo.org/es-pdf-S000173102200922X .

7. Rivera González M. Seguimiento clínico de neurofibromatosis tipo 1 en edad pediátrica. [Tesis]. Valladolid: Universidad de Valladolid; 2022 [citado 20/12/2024]. Disponible en: https://uvadoc.uva.es/bitstream/handle/10324/47635/TFG-M2185.pdf .

8. Orraca M. Caracterización epidemiológica, clínica y genética de la neurofibromatosis 1 en la provincia Pinar del Río. [Tesis]. La Habana: Universidad de Ciencias Médicas La Habana; 2012 [citado 03/06/2020] Disponible en: https://tesis.sld.cu/index.php?P=FullRecord&ID=238&ReturnText=Search+Results&ReturnTo=index.php%3FP%3DAdvancedSearch%26Q%3DY%26FK%3Dneurofibromatosis .

9. Velázquez Y, Morales M, Torres JE. Caracterización de los pacientes en genodermatosis en Las Tunas 30 años de estudio. Ciencia e innovación tecnológica. Las Tunas: Académica universitaria; 2019.

10. Velázquez Y, Valenciano CR. Genodermatoses in Las Tunas province, Cuba, 1989-2019. Rev MEDICC Review [Internet]. 2021 [citado 07/01/2022]; 23(2):34-41. Disponible en: https://mediccreview.org/wp-content/uploads/2021/04/MRApril2021-velazquez-genodermatoses-tunas-cuba.pdf .

11. Gómez-López MT, Botero-Meneses JS, Tierradentro-García LO, Vélez-van-Meerbeke A. Neuroibromatosis tipo l: relación genotipo-fenotipo. Acta Neurol Colomb. [Internet]. 2020 [citado 12 /03/2022]; 36(2):93-9. Disponible en: http://www.scielo.org.co/pdf/anco/v36n2/2422-4022-anco-36-02-93.pdf .

12. Denayer E, Legius E. Legius Syndrome and its Relationship with Neurofibromatosis Type 1. Acta Derm Venereol [Internet]. 2020 [citado 12/03/2025]; 100(7):161-8. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9128993/pdf/ActaDV-100-7-5689.pdf .

13. Online Mendelian Inheritance in Man. Legius syndrome OMIM [Internet]. Baltimore: OMIM. 2024 [citado 08/01/2024] Disponible en: https://omim.org/611431 .

14. Orpanet. Síndrome de Legius. [Internet]. Paris: Orphanet. 2020 [citado 08/01/2022] Disponible en: https://www.orpha.net/137605 .

15. Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med [Internet]. 2021 [citado 12/03/2025];23(8):1506-13. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8354850/pdf/41436_2021_Article_1170.pdf .

16. Velázquez Y, Batista M, Espinosa D, Orraca M, Pérez D. Metodología para la atención integral a pacientes con genodermatosis. Multimed [Internet]. 2022 [citado 20/12/2024];26(6): e2668. Disponible en: https://revmultimed.sld.cu/index.php/mtm/article/view/2668/2555 .

17. World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA [Internet]. 2025 [citado 12/03/2025]; 333(1):71-4. Disponible en: doi:10.1001/jama.2024.21972 .

18. Duat A, Martos GA, Martín Y, Hernández A, Espejos JM, Ruiz ML, et al. Características fenotípicas y genéticas en la neurofibromatosis tipo 1 en edad pediátrica. Anal. Ped [Internet]. 2015 [citado 23/06/2024]; 83(3):173-82. Disponible en: https://www-analesdepediatria-org.translate.goog/en-phenotypic-genetic-features-in-neurofibromatosis-articulo-S2341287915001490?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc .

19. Sánchez Marco SB. Neurofibromatosis tipo 1 y síndrome de Legius en el servicio de pediatría del hospital Miguel Servet y experiencia con las hojas de información. [Tesis doctoral]. Zaragoza: Universidad de Zaragoza; 2021. [citado 08/01/2022]. Disponible en: https://zaguan.unizar.es/record/106189/files/TESIS-2021-161.pdf .

20. García FJ, Duat A, Andrés E, Torrelo A, Noguera L, Hernández A. Hallazgos cutáneos no considerados criterios diagnósticos de la NF1. Estudio de casos y controles. Actas Dermo-Sifiliogr [Internet]. 2022 [citado 08/01/2022]; 113(10):923-9. Disponible en: http://dx.doi.org/10.1016/j.ad.2022.05.014 .

21.Collazo T. Técnicas de biología molecular aplicadas al diagnóstico de enfermedades genéticas. Rev Cubana Genética Comunitaria [Internet]. 2020 [citado07/01/2022]; 13(1): e99. Disponible en: https://revgenetica.sld.cu/index.php/gen/article/view/99/138 .

22. Evans DG, Bowers N, Burkitt E, Miles E, Garg S, Scott V. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only. EBioMedicine [Internet]. 2016 [citado 12/03/2025]; 7:212-20.

Published

2025-03-19

How to Cite

1.
Velázquez Avila Y, Rodríguez Torres TP, Rodríguez Carbonell L, Feria Rosales O, López Toranzo Y. Proposal of modification of the diagnostic approaches de neurofibromatosis type 1. RM [Internet]. 2025 Mar. 19 [cited 2025 Jun. 6];29:e2670. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/2670

Issue

Section

ARTÍCULOS ORIGINALES